Gilead writes $2.4B off Trodelvy as CEO underscores focus fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
E&G Advisors LP trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,829 shares of the biopharmaceutical company’s stock after selling 900 shares during the […]
CENTRAL TRUST Co lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 23,571 shares of the biopharmaceutical company’s stock after selling 294 shares during the period. CENTRAL TRUST Co’s holdings in Gilead Sciences […]